Enjoy complimentary customisation on priority with our Enterprise License!
The protein engineering market size is forecast to increase by USD 2.38 billion between 2022 and 2027, accelerating at a CAGR of 15.42%. In 2017, the US held the largest market share, projecting an annual revenue of USD 353.73 million. The convergence of various cutting-edge technologies, including artificial intelligence (AI), computational biology, and structural analysis, has paved the way for the creation of integrated tools offering comprehensive solutions to overcome environmental challenges in protein engineering.
To learn more about this report, Download Report Sample
The instruments segment was valued at USD 649.40 million in 2017. Within the instruments segment, a diverse range of instruments is utilized. These include high-performance liquid chromatography (HPLC) systems, mass spectrometers, nuclear magnetic resonance (NMR) spectrometers, protein crystallization platforms, and automated protein expression systems.The instruments segment facilitates protein engineering by accelerating processes that were previously time- and labor-intensive. The growing demand for biopharmaceuticals, including monoclonal antibodies, enzymes, and therapeutic proteins, has driven the need for advanced tools to facilitate the detection, optimization, and production of these complex molecules. The convergence of various technologies, such as AI, computational biology, and structural analysis, has led to the creation of integrated tools that provide comprehensive solutions to overcome environmental challenges. Thus, such factors will drive the growth of the segment during the forecast period.
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market in North America is heavily focused on biopharmaceutical applications. The development of new therapeutic proteins, including monoclonal antibodies, enzymes, and cytokines, is a driving force in North America, supported by the region's expertise in drug discovery and development biology.
Furthermore, the North American region is home to many leading pharmaceutical companies, biotech companies, and research institutes that are at the forefront of advances. North America has always been at the forefront of technological innovation related to protein engineering. North America is at the forefront of advances in computational modeling, structural biology engineering, and AI-based approaches that enable rapid protein design, optimization, and characterization. Collaborations between academia, industry, and research institutions are common in North America. Hence, such factors are expected to drive market growth in this region during the forecast period.
To understand geographic trends Download Report Sample
The market is witnessing significant growth driven by advancements in biotechnology and pharmaceutical research, with notable contributions from institutions like Eindhoven University of Technology. This market is fueled by the increasing prevalence of chronic diseases, spurring the development of targeted therapies and precision medicine approaches, particularly in cancer treatment. The emergence of AI-designed proteins and bioluminescent testing kits is revolutionizing the field, enabling researchers to generate biomedicines with enhanced efficacy. Monoclonal antibodies, insulin, and other protein-based therapies are gaining traction, offering promising outcomes for patients with cancer and autoimmune diseases. Synthetic biology plays a pivotal role in the production of these protein-based drugs, augmenting the capabilities of biotechnology and pharmaceutical businesses. As the market continues to evolve, stakeholders are closely monitoring buying behavior, patient outcomes, and the adoption of protein engineering solutions in diagnostics and therapeutics.
In the food industry, consumer preference for healthier and more sustainable food choices has driven demand for new proteins with improved nutritional profiles. It allows the development of proteins with optimized amino acid compositions, improved digestibility, and reduced allergenicity. Furthermore, it plays a central role in industrial processes. Enzymes, which are specialized proteins, are widely used as biological catalysts in various industrial applications. By designing enzymes with greater activity, stability, and specificity, end-user industries such as biofuels and detergents can realize more efficient production processes more efficient and more environmentally friendly. Hence, these factors are expected to fuel the growth of the global market share during the forecast period.
The Protein Engineering Market is fragmented in nature. Some significant players include Agilent Technologies Inc., Amgen Inc., Bio Rad Laboratories Inc., Bruker Corp., Danaher Corp., Eli Lilly and Co., General Electric Co.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
GenScript Biotech Corp., Merck KGaA, New England Biolabs Inc., Novo Nordisk AS, PerkinElmer Inc., Promega Corp., Thermo Fisher Scientific Inc., and Waters Corp.
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 - 2027.
The Market is witnessing remarkable growth driven by advancements in biotechnology and pharmaceutical businesses. With a focus on precision medicine and personalized therapies, protein-based therapies are becoming increasingly vital in treating chronic diseases like cancer, autoimmune diseases, and cardiovascular conditions. Innovations in AI-designed proteins and rational protein design are revolutionizing the field, enabling the generation of biomedicines tailored to individual patient needs. Private and public investments fuel research and development spending, leading to the development of targeted therapies and personalized diagnostics. Key stakeholders, including Ginkgo Bioworks and Centers for Disease Control and Prevention (CDC), play crucial roles in shaping the market landscape. With a focus on improving patient outcomes and addressing chronic and lifestyle disorders, the Protein Engineering Market continues to thrive, supported by ongoing advancements in synthetic biology and enzyme R&D.
Moreover, the market is experiencing remarkable growth driven by advancements in biomedicines and the increasing prevalence of chronic and lifestyle disorders like diabetes and cardiovascular issues. Bioluminescent diagnostic kits are revolutionizing cancer treatment and diagnosis, particularly in breast cancer detection, aided by the insights provided by Canadian Cancer Statistics. Protein therapeutics, including insulin and erythropoietin, play crucial roles in addressing protein deficiency disorders and immune system modulation. With a focus on R&D spending, companies are developing innovative protein-based vaccines and non-protein drugs, catering to diverse medical needs. Ginkgo Enzyme Services and manufacturing processes are integral to protein type development, ensuring product and service quality. The market's growth is also fueled by investments in cardiovascular repair and addressing coagulation and colony-stimulating factors, showcasing changing buying behaviors towards protein-based treatments.
Additionally, the Market is experiencing significant growth driven by advancements in biomedicines and the increasing prevalence of chronic and lifestyle disorders. Protein engineering techniques enable the development of innovative bioluminescent diagnostic kits and testing kits, catering to diverse healthcare needs. Moreover, the market benefits from the rising demand for coagulation factors and interferons, essential in treating various medical conditions. Conference and webinar materials facilitate knowledge exchange and drive research in protein engineering, supported by funds allocated for biomedicine research. Host strains play a crucial role in biomedicine production, ensuring product and service quality. Protein engineering addresses critical healthcare challenges such as Protein-Energy Malnutrition (PEM), offering promising solutions to improve patient outcomes and combat disease. With the continuous evolution of protein engineering technologies, the market is poised for sustained growth and innovation.
Protein Engineering Market Scope |
|
Report Coverage |
Details |
Page number |
161 |
Base year |
2022 |
Historic period |
2017 - 2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 15.42% |
Market growth 2023-2027 |
USD 2.38 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
14.29 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, UK, Germany, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Agilent Technologies Inc., Amgen Inc., Bio Rad Laboratories Inc., Bruker Corp., Danaher Corp., Eli Lilly and Co., General Electric Co., GenScript Biotech Corp., Merck KGaA, New England Biolabs Inc., Novo Nordisk AS, PerkinElmer Inc., Promega Corp., Thermo Fisher Scientific Inc., and Waters Corp. |
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.